Recent Press Releases

Nanoshuttle wear and tear: It's the mileage, not the age

As nanomachine design rapidly advances, researchers are moving from wondering if the nanomachine works to how long it will work. This is an especially important question as there are so many...

FDA Approves Pulmozyme with eRapid Nebulizer; CF Patients See 2 - 3 Minute Treatment Times

RICHMOND, Va., Jan. 26, 2015 /PRNewswire/ -- The eRapid Nebulizer System (eRapid) from PARI has been approved as the first electronic nebulizer by the Food and Drug Administration to deliver...

Glide Appoints Albany Molecular Research for Manufacture of Novel Octreotide Solid Dose Formulation Clinical Trial Product

OXFORD, England, January 26, 2015 /PRNewswire/ -- Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today...

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Liposomal Encapsulated Paclitaxel for the Treatment of Ovarian Cancer

January 26, 2015: 08:00 AM ET Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems,...

Shire's Investigational SHP609, idursulfase-IT, Receives FDA Fast Track Designation for the Treatment of Neurocognitive Decline Associated with Hunter Syndrome

LEXINGTON, Massachusetts, January 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the United States Food and Drug Administration (FDA) has granted Fast Track designation...

Yissum and PhytoTech Medical to Collaborate on Novel Delivery System for Medical Cannabis

January 26, 2015 05:50 AM Eastern Standard Time JERUSALEM--()--Yissum Research Development Company Ltd., the technology transfer company of the Hebrew University of Jerusalem,...

SPIRIVA® RESPIMAT® (tiotropium bromide) Inhalation Spray Now Available in the United States

New choice between mist and dry powder inhalers for tiotropium SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term,...

Celator Pharmaceuticals Receives FDA Fast Track Designation For CPX-351 For The Treatment Of Elderly Patients With Secondary Acute Myeloid Leukemia

EWING, N.J., Jan. 20, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (NASDAQ: CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products to...

Needle-Free Transdermal Delivery Startup Prometheon Pharma Opens Platform to Promote Industry Partnerships

January 13, 2015 09:21 AM Eastern Standard Time GAINESVILLE, Fla.--()--As the biotech industry and investors converge on San Franscisco for the JP Morgan Healthcare Conference,...

BioLight invests in newly-formed ophthalmic company

BioLight Life Sciences Investments Ltd. (OTC: BLGTY, TASE: BOLT), a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, today announced...

Intersect ENT Announces Preliminary 2014 Financial Results

MENLO PARK, Calif., Jan 12, 2015 (GLOBE NEWSWIRE via COMTEX) -- Intersect ENT, Inc. XENT, +2.43% a company dedicated to improving the quality of life for patients with ear, nose and throat...

Tekmira Pharmaceuticals and OnCore Biopharma Announce Merger Agreement to Create Leading Global Hepatitis B Virus Company

Transaction Highlights: New industry-leading company expected to capitalize on the HBV global market opportunity. Eight unique drug candidates to be used in combination to develop a curative...

Capsugel Acquires Monash University's Proprietary Ionic Liquids Technology

Technology offers a novel approach to improving the solubility of lipid and liquid-based drugs. Morristown, N.J., and Melbourne, Australia, January 12, 2015 – Capsugel and Monash University...

Celator® Pharmaceuticals Announces Publication Of Promising Phase 2 Data For CPX-351 In First Relapse Acute Myeloid Leukemia Patients

Published: Jan 12, 2015 7:00 a.m. ET Data Show Significant Survival Improvement with CPX-351 in Poor-Risk Patients - EWING, N.J., Jan. 12, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.CPXX,...

AbbVie Announces U.S. FDA Approval of DUOPA™ (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease

-- DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease -- In a clinical trial, patients treated...

Alnylam and Isis Form New Agreement, Extending Decade-Long Partnership for Leadership in RNA Therapeutics

January 09, 2015 07:00 AM Eastern Standard Time New Agreement Includes Cross-License on Four Disease Targets, Providing Each Company Exclusive RNA Therapeutic License Rights for Two Programs...

NIH grants aim to decipher the language of gene regulation

The National Institutes of Health has awarded grants of more than $28 million aimed at deciphering the language of how and when genes are turned on and off. These awards emanate from the recently...

'Flying carpet' technique uses graphene to deliver one-two punch of anticancer drugs

NORTH CAROLINA STATE UNIVERSITY An international team of researchers has developed a drug delivery technique that utilizes graphene strips as "flying carpets" to deliver two anticancer...

EnGeneIC Completes $10 Million Series B Financing Led by U.S. Institutional Investor

Funds Enable Further Clinical Development of Targeted Cancer Nanotherapies NEW YORK and SYDNEY, Jan. 6, 2015 /PRNewswire/ -- EnGeneIC, Ltd., an emerging biopharmaceutical company focused on...

Tonix Pharmaceuticals Provides Clinical and Regulatory Update on its Continued Development of TNX-102 SL in Fibromyalgia

Phase 3 Program to Begin in the Second Quarter of 2015 NEW YORK, Jan. 6, 2015 -- Tonix Pharmaceuticals Holding Corp. (TNXP) has received written guidance from the U.S. Food and Drug Administration...